BACK TO NEWS FEED

1 year ago

OSL Brachytherapy

Oncosil Medical Limited (OSL, NeuroDiscovery Ltd) is an Australia-based company
which is engaged in the development of an innovative brachytherapy (internal
radiotherapy) product, OncoSil, for the treatment of pancreatic cancer, after
its acquisition of Enigma Therapeutics Ltd, a UK based cancer company.

Volume coming in on the breakout.  RSI,CCI giving a buy signal. Weekly support level at 13c, Stop set at 13c.

OSL